Source: Annals of oncology

Index Terms: Cancérologie, Antibodies, Monoclonal, Humanized -- adverse effects -- pharmacology -- therapeutic use, Antineoplastic Agents -- adverse effects -- pharmacology -- therapeutic use, Breast Neoplasms -- drug therapy -- metabolism, Dimerization, Disease-Free Survival, Female, Humans, Receptor, ErbB-2 -- immunology -- metabolism, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article

URL: https://dipot.ulb.ac.be/dspace/bitstream/2013/135471/4/doi_118037.pdf
https://dipot.ulb.ac.be/dspace/bitstream/2013/135471/1/136.AnnOncol-Capelan-2012.pdf
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/135471
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL

Source: Annals of oncology

Index Terms: Cancérologie, Antibodies, Monoclonal, Humanized -- adverse effects -- pharmacology -- therapeutic use, Antineoplastic Agents -- adverse effects -- pharmacology -- therapeutic use, Breast Neoplasms -- drug therapy -- metabolism, Dimerization, Disease-Free Survival, Female, Humans, Receptor, ErbB-2 -- immunology -- metabolism, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article

URL: https://dipot.ulb.ac.be/dspace/bitstream/2013/135471/4/doi_118037.pdf
https://dipot.ulb.ac.be/dspace/bitstream/2013/135471/1/136.AnnOncol-Capelan-2012.pdf
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/135471
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL